GSK is Fighting Fake Drugs with ConsenSys Startup ‘Viant’ for Blockchain in Pharmaceuticals
One of the world’s biggest pharma companies, GlaxoSmithKline is working with Ethereum-based ConsenSys startup Viant to develop blockchain in pharmaceuticals. With the release of new regulations to protect U.S. consumers from fake, contaminated and stolen medications, the pilot could not have come at a better time. Furthermore, the immutable ledger aims to combat $200 billion in lost sales each year.
Read More